معرفی
Yinghua Ma serves as Assistant Professor of Research in Neuroscience at the Brain and Mind Research Institute, Weill Cornell Medical College since 2013. Her work bridges neuroimmunology and microbiome research with a primary focus on multiple sclerosis pathogenesis.
Her educational background includes a B.S. from East China University of Science and Technology (1994) and a Ph.D. from Shanghai Institute of Cell Biology (2001).
- B.S., East China University of Science and Technology, 1994
- Ph.D., Shanghai Institute of Cell Biology, 2001
Dr. Ma's research centers on neuroimmune interactions in multiple sclerosis, specifically investigating how gut microbiome components like Clostridium perfringens epsilon toxin compromise the blood-brain barrier and trigger demyelination. Her work integrates neuroimaging, molecular neuroscience, and immunological approaches to study myelin repair mechanisms, oligodendrocyte vulnerability, and the role of Toll-like receptors in neurodegeneration. Current projects explore the gut-brain axis in CNS autoimmunity using humanized zebrafish models and advanced MRI techniques.
Analysis of her publication record reveals a consistent trajectory from fundamental neurodevelopmental studies (Purkinje neuron biology, GABA transporters) toward translational neuroimmunology. Recent work (2018-2023) demonstrates increasing specialization in microbiome-CNS interactions, with epsilon toxin research emerging as a dominant theme. Her methodology spans molecular techniques, in vivo modeling, and clinical neuroimaging, reflecting an interdisciplinary approach to understanding multiple sclerosis mechanisms.
Dr. Ma actively contributes to major research initiatives as Co-Investigator:
- NIAID grant (2023-2028): Immune Privilege, CNS Autoimmunity, and C. perfringens Epsilon Toxin
- National MS Society grant (2023-2026): Harboring the Initial Trigger of Multiple Sclerosis
- National MS Society grant (2016-2025): Quantitative MRI of Lesion Iron and Myelin Repair
She maintains active industry relationships through Astoria Biologica, Inc., holding both ownership and proprietary interests in intellectual property. Her research operates within the Brain and Mind Research Institute's collaborative ecosystem, leveraging Weill Cornell Medicine's clinical resources and interdisciplinary neuroscience infrastructure for translational studies connecting gut microbiome dysbiosis to CNS autoimmunity.
